Taiwanese tea brand Gong cha Group has closed an undisclosed investment from global growth private equity firm TA Associates. Established in 2006, Gong cha offers tea, products, and services by procuring ingredients from selected suppliers and giving customers freshly brewed tea. The company’s main product is the Taiwanese-style bubble tea, which is sweet milk tea […]
Ørsted said that the installation of the final turbine of the 120MW Formosa 1 offshore wind farm phase 2 in Taiwan has been completed. The Formosa 1 offshore wind project, which is the commercial-scale offshore wind farm in Taiwan, comprises 20 wind turbines, each of 6MW capacity. The Taiwanese offshore wind farm will be able […]
Rinchem said that it will open a new hazardous materials warehouse in Taiwan to be located in Tainan, as per the latest chemical industry news. The hazardous materials warehouse will be the second such facility for Rinchem, which is engaged in provides customized warehousing and transportation solutions for hazardous materials. The first facility has been […]
Jan De Nul Group has wrapped up the installation of all the 20 foundations for the second phase of the 120MW Formosa 1 offshore wind farm off the coast of Taiwan. The Formosa 1 offshore wind project is owned by Formosa I Wind Power, a partnership between Orsted (35%), Macquarie Capital (25%), JERA (32.5%), and […]
Danish energy company Ørsted and its partners have generated first power from the second phase of the 128MW Formosa 1 offshore wind farm located in Taiwanese waters. The second phase of the Formosa 1 project will feature 20 turbines delivered by Siemens Gamesa, which will have a combined capacity of 120MW. Each of the turbines […]
Jan de Nul’s Taiwan branch has selected Heerema Marine Contractors to install 21 jacket foundations (4 legged) for the 110MW Changhua Windfarm Phase 1 offshore wind project. Taiwan Power Company (TPC) is the owner of Changhua Windfarm Phase 1 located offshore Taiwan, 8km off the coast of Changhua county. The Taiwanese offshore wind project is […]
In a significant development within the pharmaceutical industry, Shanghai-based InventisBio has entered into a strategic partnership with Betta Pharmaceuticals Co., Ltd. to co-develop the promising lung cancer drug D-0316. Under this agreement, InventisBio has out-licensed the rights to D-0316 in China, Hong Kong, and Taiwan to Betta Pharmaceuticals Co., Ltd. in a deal valued at […]
TWi Biotechnology, a Taiwanese biopharmaceutical company, has initiated the enrollment of patients in a pivotal Phase 2 clinical trial evaluating its investigational drug, AC-203, for the treatment of inherited Epidermolysis Bullosa (EB). This trial marks a significant advancement in the quest for effective therapies for this challenging condition. The Phase 2 trial of AC-203 is […]